PERSEUS SOROS BIOPHARMACEUTICAL FUND LP

CIK 1111408 · last filed 2010-05-13

PERSEUS SOROS BIOPHARMACEUTICAL FUND LP is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2010. The most recent filing, for MAPP, was dated May 13, 2010. The firm reports its address in Washington, DC. 21 SEC filings were submitted jointly with PERSEUS SOROS PARTNERS LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

Companies

Total Filings

Lifetime Open-Market Net

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

MAPP price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address

ARMY & NAVY CLUB BLDG
1627 I ST NW STE 610
WASHINGTON, DC 20006

Phone

(212) 651-6389

Related Filers

PERSEUS SOROS PARTNERS LLC — 21 joint filings, latest 2007-10-12

SFM AH LLC — 21 joint filings, latest 2007-10-12

SFM PARTICIPATION LP — 21 joint filings, latest 2007-10-12

PERSEUS BIOTECH FUND PARTNERS LLC — 19 joint filings, latest 2007-07-12

PERSEUSPUR LLC — 19 joint filings, latest 2007-07-12

SOROS FUND MANAGEMENT LLC — 19 joint filings, latest 2007-10-12

George Soros — 19 joint filings, latest 2007-10-12

Frank H Pearl — 17 joint filings, latest 2007-07-12

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
MAP Pharmaceuticals, Inc. (MAPP) Delisted	10%+ Owner	1,826,169	$28.11	$51.33M	$0	2	2010-05-13

Recent Filings

2 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2010-05-13	MAP Pharmaceuticals, Inc. (MAPP) Delisted	Other (J)	−1,000,000	$0	EDGAR
2010-02-16	MAP Pharmaceuticals, Inc. (MAPP) Delisted	Other (J)	−1,250,000	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.